Private Advisor Group’s Eli Lilly LLY Stock Holding History

Private Advisor Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.6M	Sell	86,496 -634	-0.7%	-$643K	0.37%	43
2025 Q4	$93.6M	Buy	87,130 +4,571	+6%	+$4.37M	0.44%	36
2025 Q3	$63M	Sell	82,559 -838	-1%	-$624K	0.31%	58
2025 Q2	$65M	Buy	83,397 +2,331	+3%	+$1.81M	0.35%	52
2025 Q1	$67M	Buy	81,066 +237	+0.3%	+$197K	0.41%	41
2024 Q4	$62.4M	Sell	80,829 -467	-0.6%	-$387K	0.35%	55
2024 Q3	$72M	Buy	81,296 +895	+1%	+$805K	0.45%	33
2024 Q2	$72.8M	Buy	80,401 +4,119	+5%	+$3.29M	0.49%	32
2024 Q1	$59.3M	Buy	76,282 +130	+0.2%	+$92.5K	0.43%	40
2023 Q4	$44.4M	Buy	76,152 +3,222	+4%	+$1.88M	0.35%	59
2023 Q3	$39.2M	Buy	72,930 +434	+0.6%	+$224K	0.35%	59
2023 Q2	$33.8M	Buy	72,496 +1,265	+2%	+$531K	0.29%	74
2023 Q1	$24.5M	Buy	71,231 +2,207	+3%	+$744K	0.23%	88
2022 Q4	$5.48M	Buy	69,024 +5,737	+9%	+$2.03M	0.28%	76
2022 Q3	$20.5M	Sell	63,287 -44,936	-42%	-$14.2M	0.24%	93
2022 Q2	$35.1M	Buy	108,223 +10,694	+11%	+$3.21M	0.31%	68
2022 Q1	$27.9M	Sell	97,529 -1,586	-2%	-$408K	0.21%	95
2021 Q4	$27.4M	Sell	99,115 -46,021	-32%	-$11.7M	0.21%	95
2021 Q3	$33.5M	Buy	145,136 +59,135	+69%	+$14.6M	0.21%	93
2021 Q2	$19.7M	Sell	86,001 -8,035	-9%	-$1.61M	0.17%	119
2021 Q1	$17.6M	Buy	94,036 +34,792	+59%	+$6.81M	0.17%	127
2020 Q4	$10M	Sell	59,244 -940	-2%	-$140K	0.1%	203
2020 Q3	$9.11M	Buy	60,184 +580	+1%	+$89.8K	0.12%	182
2020 Q2	$9.79M	Buy	59,604 +922	+2%	+$142K	0.14%	155
2020 Q1	$8.14M	Buy	58,682 +701	+1%	+$96.3K	0.15%	151
2019 Q4	$7.62M	Sell	57,981 -2,426	-4%	-$281K	0.12%	190
2019 Q3	$6.76M	Sell	60,407 -48,271	-44%	-$5.37M	0.11%	204
2019 Q2	$12M	Buy	108,678 +57,755	+113%	+$6.8M	0.22%	106
2019 Q1	$6.6M	Sell	50,923 -785	-2%	-$95.5K	0.13%	171
2018 Q4	$5.98M	Sell	51,708 -9,122	-15%	-$1.02M	0.14%	157
2018 Q3	$6.53M	Buy	60,830 +21,056	+53%	+$2.11M	0.13%	157
2018 Q2	$3.41M	Buy	39,774 +7,084	+22%	+$582K	0.06%	164
2018 Q1	$2.53M	Sell	32,690 -17,709	-35%	-$1.43M	0.1%	209
2017 Q4	$4.33M	Sell	50,399 -23,122	-31%	-$1.97M	0.18%	118
2017 Q3	$6.39M	Buy	73,521 +3,615	+5%	+$296K	0.16%	144
2017 Q2	$5.75M	Sell	69,906 -12,173	-15%	-$993K	0.16%	149
2017 Q1	$6.18M	Buy	82,079 +15,130	+23%	+$1.21M	0.17%	134
2016 Q4	$5.04M	Buy	66,949 +7,496	+13%	+$558K	0.17%	132
2016 Q3	$4.82M	Sell	59,453 -1,235	-2%	-$98.9K	0.2%	119
2016 Q2	$4.86M	Buy	60,688 +9,298	+18%	+$700K	0.2%	118
2016 Q1	$3.7M	Buy	51,390 +1,101	+2%	+$83.3K	0.18%	126
2015 Q4	$4.24M	Sell	50,289 -871	-2%	-$72.3K	0.2%	114
2015 Q3	$4.28M	Sell	51,160 -5,549	-10%	-$468K	0.24%	93
2015 Q2	$4.74M	Buy	56,709 +6,504	+13%	+$496K	0.22%	88
2015 Q1	$3.65M	Sell	50,205 -12,000	-19%	-$854K	0.21%	104
2014 Q4	$4.29M	Buy	62,205 +2,774	+5%	+$187K	0.28%	83
2014 Q3	$3.85M	Sell	59,431 -1,259	-2%	-$79.7K	0.27%	89
2014 Q2	$3.77M	Buy	60,690 +4,214	+7%	+$251K	0.32%	70
2014 Q1	$3.32M	Buy	56,476 +22,024	+64%	+$1.23M	0.35%	68
2013 Q4	$1.76M	Buy	+34,452	New	+$1.73M	0.2%	114

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Private Advisor Group's LLY Position: Q1 2026 in Review

Private Advisor Group reduced its Eli Lilly (LLY) stake by 0.73% in Q1 2026, selling an estimated $643K and leaving 86,496 shares worth $79.6M. The position accounts for 0.37% of the portfolio, ranked #43.

Private Advisor Group first reported a position in LLY in Q4 2013 and has held it in 50 quarters since. The position peaked at $93.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Private Advisor Group held 86,496 shares of Eli Lilly worth $79.6M as of Q1 2026.
Private Advisor Group sold 634 Eli Lilly shares in Q1 2026, an estimated $643K.
Eli Lilly made up 0.37% of Private Advisor Group's portfolio in Q1 2026, its #43 holding.
Private Advisor Group first reported a position in Eli Lilly in Q4 2013 and has held it in 50 quarters since.
Private Advisor Group's Eli Lilly position peaked at $93.6M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.